- Home
- EIC vs SOPH Comparison
EIC vs SOPH Comparison
Compare EIC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.8M | 462.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EIC | SOPH |
|---|---|---|
| Price | $9.70 | $8.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.63 | $7.50 |
| AVG Volume (30 Days) | 88.5K | ★ 624.4K |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 13.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.17 | $3.21 |
| 52 Week High | $13.55 | $8.98 |
Technical Indicators
Market Signals| Indicator | EIC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 55.52 |
| Support Level | $9.33 | $4.63 |
| Resistance Level | $10.14 | $8.98 |
| Average True Range (ATR) | 0.12 | 0.43 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 24.59 | 58.12 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.